title: Role of nitric oxide in the convulsions following the coadministration of enoxacin with fenbufen in mice.
abstract: Effects of nitric oxide (NO) synthase inhibitors on the enoxacin-induced convulsions were examined in mice pretreated with fenbufen. 7-nitroindazole markedly suppressed the incidence of convulsions, whereas L-arginine did not modify the convulsions at all. The suppression of the convulsions by 7-nitroindazole was not reversed by the pretreatment of L-arginine. Brain NO synthase activity was significantly raised at 30 min after enoxacin when combined with fenbufen. The increased NO synthase activity was found to be suppressed by the pretreatment of 7-nitroindazole. These findings suggest that endogenous NO may be involved as a proconvulsant substance in the development of enoxacin-induced convulsions in mice pretreated with fenbufen.
authors.affiliation: Department of Clinical Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Osaka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Masukawa
authors.forename: K
authors.initials: K
authors.lastname: Nakanishi
authors.forename: R
authors.initials: R
authors.lastname: Natsuki
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D001921:Brain / Q000201:enzymology; D015365:Enoxacin / Q000008:administration & dosage / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007191:Indazoles / Q000494:pharmacology; D008297:Male; D051379:Mice; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D052248:Nitric Oxide Synthase Type I; D010654:Phenylbutyrates / Q000008:administration & dosage / Q000009:adverse effects*; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004791:Enzyme Inhibitors; D007191:Indazoles; D010654:Phenylbutyrates; D009569:Nitric Oxide; D015365:Enoxacin; C010725:fenbufen; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; C496321:Nos1 protein, mouse; C080122:7-nitroindazole